Recent News

Discovery Life Sciences To Acquire Gentest Business From Corning Incorporated

Biospecimen Leader to Combine Gentest with Recent IVAL Acquisition to Create Leading In Vitro Drug Metabolism Services Offering
Read More
Cryopreserved Leukopaks: Addressing the Viability Myth

Cryopreserved Leukopaks: Addressing the Viability Myth

Recent publications, including a landmark paper from Novartis¹, demonstrate the viability and utility of cryopreserved leukopaks, dispelling the viability myth.
Read More
Addressing the Achilles Heel of T-Cell Therapy

Addressing the Achilles Heel of T-Cell Therapy

Cryopreserved leukopaks eliminate the constraints imposed by a reliance on fresh human cells for T-cell therapies. Has the tide turned in favor of frozen cells?
Read More

SOT 2022 Presentation By Dr. Albert Li – March 28, 2022

Dr. Albert Li presents Discovery Life Science’s Hepatocyte and Enterocyte products. In this presentation, Dr. Li discusses the technology, applications, and advantages of Discovery’s ADMET products.
Read More